March 29, 2019
Mayo Clinic in the News Weekly Highlights for March 29, 2019
By Emily Blahnik
Reuters, Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value by Julie Steenhuysen — Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease drug aducanumab, a major setback in the quest to find a treatment for the mind-wasting disease and a blow to Biogen, […]
View full entry
Tags: AliveCor, alzheimer's disease, anal cancer, artificial Intelligence, Biogen, blood donation, Blood Donor Program, caffeine, cognitive decline, dementia, depression, Derrick Rose
February 22, 2019
Mayo Clinic in the News Weekly Highlights for February 22, 2019
By Emily Blahnik
Wall Street Journal, The Fitness Plan for Serious Schmoozers by Jen Murphy — “You really need to make an effort to counteract the effects of sitting for eight hours a day,” says Donald Hensrud, director of the Healthy Living Program at the Mayo Clinic in Rochester, Minn. “Just being active won’t cut it. You need […]
View full entry
Tags: Alexa, alzheimer's disease, Anatomage Table, anesthesia, aquatic physical therapy, asthma, Big Blue Dragon Boat, blood sugar, board of trustees, burnout, caregivers, cervical cancer